-
"PNAS" big breakthrough! Scientists from the three countries jointly developed a new "detoxification version" of erythromycin, the side effects greatly reduced!
Time of Update: 2020-07-14
The drug could be adjusted to reduce its toxic side effects, especially heart damage, without impairing its ability to suppress tumors, according to a new study The study upended conventional thinki
-
Summary of recent important research progress in the treatment of stomach cancer
Time of Update: 2020-07-14
The combination of L1 methylation and tumor-immersed lymphocytes can be used as a prognosis for advanced gastric cancer , the researchers used CD3 immuno tissue chemistry and pyrophosphate
-
Nature: Mitochondria ubiquitin oxidation is a necessary condition for tumor growth
Time of Update: 2020-07-14
Mitochondrial electron transfer chain (ETC) is essential for tumor growth, combined with targeted therapy, etc inhibition has been shown to have anti-tumor effect In addition, the human brain and lu
-
CheckMate-870 results are positive: Odivor (Navuliu monotophosm) is safe and reliable in patients with advanced or metastatic non-small cell lung cancer (NSCLC)
Time of Update: 2020-07-14
On June 30, 2020, The Results of CheckMate-870 were presented at the American Association for Cancer Research's Annual Meeting (AACR 2020) CheckMate-870 is an open-label phase IIIB clinical study de
-
Science Advances: New Brazilian study: Genetic variation increases risk of cancer
Time of Update: 2020-07-14
Variationin in biology refers to various differences between biological species and individuals, including morphology, physiology, biochemistry and behavior, habits and other aspects of differences,
-
Antibody drug conjugatetro Trodelvy significantly improves PFS: Phase III study reaches end in patients with triple-negative breast cancer
Time of Update: 2020-07-14
Immunomedics announced that its antibody drug, the conjugate Trotecan-hziy, was used in patients with three negative breast cancer (TNBC), who had previously received at least two anti-metastasis
-
GnRH antagonist linzagolix treats uterine fibroids, with positive results in Phase 3 studies
Time of Update: 2020-07-14
ObsEva SA announced data from the 3rd Phase study (PRIMROSE 1 and 2), which evaluated the effectiveness and safety of the GnRH (gonadotropin-releasing hormone) an tagane Yselty (linzagolix) for the
-
Chinese experts focus on early, accurate and fine lung cancer, and the original diagnosis greatly improves the rate of early diagnosis
Time of Update: 2020-07-13
Lung nodule detection rate increased from 77.3% to 89.3%, early lung cancer diagnosis the correct rate reached 94.7%, pure mill glass density nodule syllatatry judgment accuracy of 93% Reporte
-
Ann Hematol: Primary Central Nervous System Lymphoma in China
Time of Update: 2020-07-13
Primary central nervous system lymphoma (PCNSL) is a rare form of ligand-type non-Hodgkin lymphoma, and a few cases have been reported in China The study was designed to investigate the clinical p
-
Cancer: Nemotto bead singofa vs. simple cisplatin radiotherapy treatment of local advanced head and neck cancer effect
Time of Update: 2020-07-13
In a Phase 2 study, adding nimottozumab to chemotherapy in patients with local advanced head and neck cancer improved efficacy, so a phase 3 study was conducted to confirm these findings the ope
-
J Clin Oncol: Primain's effect on radiation-related neuropathic pain in patients with head and neck cancer
Time of Update: 2020-07-13
In patients with radiotherapy for head and neck cancer, neuropathic pain is an inevitable treatment-related adverse event The purpose of this study was to test the efficacy and safety of Pribarin's
-
Professor Liu Jian: China's biosimilardrugs meet international standards to meet the affordable drug needs of breast cancer patients
Time of Update: 2020-07-13
Breast cancer is the highest incidence of malignant tumors in women, the 5-year survival rate of about 70% to 90%, is also the number one cause of cancer death in women HER2-positive breast cancer
-
J Immuno Cancer: A Comparative Analysis of Phase III Clinical Trials for The Treatment of Head and Neck Squamous Cell Carcinoma Patients with Anti-PD1 Single Drug
Time of Update: 2020-07-13
Two Phase III clinical trials (CheckMate 141 and KEYNOTE 040) have independently demonstrated that the total lifetime (OS) of patients with failed platinum-based treatment can be improved with anti-
-
PD-1 Monoantida KEYTRUDA: FDA approved for the first treatment of recurrent or metastatic skin squamous cell carcinoma
Time of Update: 2020-07-13
Merck announced that the U.S Food and Drug Administration Administration ( FDA ) has approved its anti-PD-1 monoanti-keyTRUDA as a monodrug therapy for patients with recurrent or metastatic skin s
-
Am J Clin Nutr: Oral glutamine treatment effects on oral mucositis and dermatitis in patients with head and neck cancer caused by radiation
Time of Update: 2020-07-13
Glutamine is the main energy of the gastrointestinal epithelial, maintaining the mucous membrane structure Tumor patients often experience oral mucositis, which can lead to an unexpected interruptio
-
Nat Med: Liquid biopsy can accurately detect early kidney cancer
Time of Update: 2020-07-13
Kidney cancer is a common malignant tumor in urology, the incidence rate accounts for 2% to 3% of adult malignant tumors, although there are many symptoms of kidney cancer, but the diagnosis of kid
-
Cell: Seize the cancer 'metabolic weakness'! Real-time metabolic tracking and fat-free diet, good efficacy of tumor diagnosis and treatment
Time of Update: 2020-07-13
Often, cancer cells rely heavily on breaking down fat to promote their own growth and spread A new study has found that surgical "iKnife" can capture this weakness of cancer cells, and then use a co
-
Samsung Bioepis's Beval sing-it-againbiolya AYBINTIO is positively rated by CHMP
Time of Update: 2020-07-13
South Korea's Samsung Bioepis recently announced that the European Drug Administration Bureau (EMA) of the Human Drug Commission (CHMP) is positive about AYBINTIO, the drug is a biosimilar of befl
-
Melanoma seokons for post-treatment progress immunity after anti-PD-1/PD-L1 treatment: G protein estrogen receptor agonisant LNS8801 obtained FDA fast track
Time of Update: 2020-07-13
Linnaeus Therapeutics announced that the U.S Food and Drug Administration ( FDA ) has granted LNS88801 fast track designations for the treatment of metastatic or non-removable melanoma patients w
-
Radiat Oncol: Low-level laser treatment for head and neck tumor mucositis
Time of Update: 2020-07-13
Low-level laser therapy (LLLT), also known as photobiotic therapy (PBMT), can reduce the incidence and severity of oral mucositis (OM) in patients with head and neck cancer who receive chemical radi